Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2026-06-02 17:35:21 ET · period of report 2026-06-01 · accession 0001628280-26-039943 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-02 17:35 | 2026-06-01 | VIR | Napolitano Janet | Dir | S - Sale | $9.45 | -3,200 | 21.2K | -13% | -$30.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | S | D | 3,200 | $9.45 | 21,216 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025. |